Drug Pipeline

NeoVax Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
2
Top Sponsors
Active Studies by Phase
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT03219450 A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With… Lymphocytic Leukemia Recruiting
NCT02950766 NeoVax Plus Ipilimumab in Renal Cell Carcinoma Kidney Cancer Active, Not Recruiting
NCT04930783 NeoVax + CDX-301 and Nivolumab or Pembrolizumab in Melanoma Melanoma Active, Not Recruiting
Sponsors Running NeoVax Trials
Dana-Farber Cancer Institute (2) Patrick Ott, MD, PhD (1)
Disease Areas
Kidney Cancer (1) Leukemia (1) Melanoma (1)
Get alerts when NeoVax trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free